Skip to content

Awards

Ziskind Clinical Research Scholar Award

ADVERTISEMENT
Morton Ziskind, MD
Photo courtesy of Tulane University Archives

The Ziskind Clinical Research Scholar Award recognizes pulmonary and critical care fellows who demonstrate exceptional promise as clinical researchers and future leaders in the American Thoracic Society (ATS). The one-time $5,000 award honors Morton Ziskind, MD, a Tulane University clinician-researcher and mentor whose legacy includes supporting the growth of young investigators and their engagement with the ATS community.

Meet previous Ziskind Clinical Research Scholars.

Funding for the Ziskind Clinical Research Scholar Award comes from the estate of Morton Ziskind and generous donations from his colleagues and friends. 

Nominees must be early-career ATS members with demonstrated accomplishments in leadership, scholarship, academic achievement, and involvement in the Society. Each nominee must be nominated by a research mentor, fellowship program director, or associate director.

ATS strongly encourages nominations of women, people with disabilities, individuals from economically disadvantaged backgrounds, and others whose lived experiences reflect limited access to advancement opportunities. Nominations of international researchers are also encouraged. For this award, ATS defines “international” as residing outside North America.

Nominations for the 2027 Ziskind Clinical Research Scholar Award open Nov. 16, 2026. 

  • Have completed an MD or DO and be enrolled in an adult or pediatric pulmonary and critical care medicine fellowship. Fellows supported by T32, F32, or comparable formal research training mechanisms remain eligible after completing the clinical portion of fellowship, provided they have not transitioned to a faculty appointment 
  • Demonstrate early success in patient-oriented research as defined by the NIH, see definition below*.
  • Not have received an extramural career development award at the time of application (e.g., K award, VA career development award, or equivalent).
  • Have submitted an abstract to the upcoming ATS International Conference.
  • Be an ATS member at the time of application.

*For this award, patient-oriented research is defined as research conducted with human subjects or on material of human origin such as tissues, specimens, and cognitive phenomena. This area of research includes: 1) mechanisms of human disease; 2) therapeutic interventions; 3) clinical trials; and 4) the development of new technologies. Excluded from this definition are in vitro studies that utilize human tissues but do not deal directly with patients. In other words, patient-oriented research is research in which it is necessary to know the identity of the patients from whom the data, cells or tissues are derived.

Start Your Application - Ziskind nominations open Nov 16th,2026

A research mentor, fellowship program director, or associate director must submit the nomination. The application includes the following:

Nomination letter (maximum two pages). Explain why the nominee is an outstanding clinical research scholar, highlighting accomplishments and potential for future leadership in patient-oriented research and within ATS. Describe institutional support and confirm that only one individual has been nominated by the institution.

Curriculum vitae. Submit the nominee’s current CV.

Personal statement (maximum one page). The nominee should describe their future goals

ATS Conference abstract. Provide a copy of the abstract submitted by the nominee to the upcoming ATS International Conference. 

Professionalism and ethical conduct attestation. Include a statement attesting to the nominee’s adherence to the ATS policy on professionalism and ethical conduct.

Important: ATS cannot accept changes or additions to nomination applications once they have been submitted.

Administrative Review

ATS staff will review nominations for completeness and compliance with the eligibility criteria and application requirements. Only complete, eligible nominations advance to committee review. 

Committee Review

The Ziskind Committee evaluates nominees holistically, considering leadership, scholarship, grant activity, and ATS involvement in the context of each individual’s career development. Particular emphasis is placed on the nominee’s trajectory and potential for excellence in patient-oriented research.

Review the key dates and deadlines for the upcoming cycle below to support your planning and ensure a smooth nomination process.

  • Nomination Opens: Nov. 16, 2026
  • Nomination Closes: Dec. 16, 2026
  • Awardee Notification: February 2027
  • Have completed an MD or DO and be enrolled in an adult or pediatric pulmonary and critical care medicine fellowship. Fellows supported by T32, F32, or comparable formal research training mechanisms remain eligible after completing the clinical portion of fellowship, provided they have not transitioned to a faculty appointment 
  • Demonstrate early success in patient-oriented research as defined by the NIH, see definition below*.
  • Not have received an extramural career development award at the time of application (e.g., K award, VA career development award, or equivalent).
  • Have submitted an abstract to the upcoming ATS International Conference.
  • Be an ATS member at the time of application.

*For this award, patient-oriented research is defined as research conducted with human subjects or on material of human origin such as tissues, specimens, and cognitive phenomena. This area of research includes: 1) mechanisms of human disease; 2) therapeutic interventions; 3) clinical trials; and 4) the development of new technologies. Excluded from this definition are in vitro studies that utilize human tissues but do not deal directly with patients. In other words, patient-oriented research is research in which it is necessary to know the identity of the patients from whom the data, cells or tissues are derived.

Start Your Application - Ziskind nominations open Nov 16th,2026

A research mentor, fellowship program director, or associate director must submit the nomination. The application includes the following:

Nomination letter (maximum two pages). Explain why the nominee is an outstanding clinical research scholar, highlighting accomplishments and potential for future leadership in patient-oriented research and within ATS. Describe institutional support and confirm that only one individual has been nominated by the institution.

Curriculum vitae. Submit the nominee’s current CV.

Personal statement (maximum one page). The nominee should describe their future goals

ATS Conference abstract. Provide a copy of the abstract submitted by the nominee to the upcoming ATS International Conference. 

Professionalism and ethical conduct attestation. Include a statement attesting to the nominee’s adherence to the ATS policy on professionalism and ethical conduct.

Important: ATS cannot accept changes or additions to nomination applications once they have been submitted.

Administrative Review

ATS staff will review nominations for completeness and compliance with the eligibility criteria and application requirements. Only complete, eligible nominations advance to committee review. 

Committee Review

The Ziskind Committee evaluates nominees holistically, considering leadership, scholarship, grant activity, and ATS involvement in the context of each individual’s career development. Particular emphasis is placed on the nominee’s trajectory and potential for excellence in patient-oriented research.

Review the key dates and deadlines for the upcoming cycle below to support your planning and ensure a smooth nomination process.

  • Nomination Opens: Nov. 16, 2026
  • Nomination Closes: Dec. 16, 2026
  • Awardee Notification: February 2027

Questions?

Contact ATS for questions about eligibility or the nomination process.